• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于测定化合物对杜氏利什曼原虫细胞内无鞭毛体形式活性的体外系统。

An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.

作者信息

Neal R A, Croft S L

出版信息

J Antimicrob Chemother. 1984 Nov;14(5):463-75. doi: 10.1093/jac/14.5.463.

DOI:10.1093/jac/14.5.463
PMID:6096347
Abstract

A method has been defined for infecting primary mouse peritoneal macrophages with amastigotes of Leishmania donovani in vitro, and analysing the response of the infected macrophages to treatment with drugs. The growth of intracellular amastigotes was inhibited by all clinically used antileishmanial drugs. Toxic effects on macrophages were observed with some drugs. Other experimental antileishmanial compounds were active in this system. This test is proposed as an initial screening test for the discovery of novel antileishmanial compounds.

摘要

已确定一种在体外将杜氏利什曼原虫无鞭毛体感染原代小鼠腹腔巨噬细胞,并分析受感染巨噬细胞对药物治疗反应的方法。所有临床使用的抗利什曼原虫药物均能抑制细胞内无鞭毛体的生长。部分药物对巨噬细胞有毒性作用。其他实验性抗利什曼原虫化合物在该系统中具有活性。该试验被提议作为发现新型抗利什曼原虫化合物的初步筛选试验。

相似文献

1
An in-vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani.一种用于测定化合物对杜氏利什曼原虫细胞内无鞭毛体形式活性的体外系统。
J Antimicrob Chemother. 1984 Nov;14(5):463-75. doi: 10.1093/jac/14.5.463.
2
Identification of the benzodiazepines as a new class of antileishmanial agent.将苯二氮䓬类药物鉴定为一类新型抗利什曼原虫药物。
Bioorg Med Chem Lett. 2007 Feb 1;17(3):624-7. doi: 10.1016/j.bmcl.2006.11.004. Epub 2006 Nov 6.
3
In vivo and in vitro antileishmanial activity of Bungarus caeruleus snake venom through alteration of immunomodulatory activity.通过改变免疫调节活性,蓝环蛇蛇毒的体内和体外抗利什曼原虫活性。
Exp Parasitol. 2013 Sep;135(1):126-33. doi: 10.1016/j.exppara.2013.06.006. Epub 2013 Jul 3.
4
A parasite rescue and transformation assay for antileishmanial screening against intracellular Leishmania donovani amastigotes in THP1 human acute monocytic leukemia cell line.一种用于在THP1人急性单核细胞白血病细胞系中针对细胞内杜氏利什曼原虫无鞭毛体进行抗利什曼原虫筛选的寄生虫拯救与转化试验。
J Vis Exp. 2012 Dec 30(70):4054. doi: 10.3791/4054.
5
Development of luciferase expressing Leishmania donovani axenic amastigotes as primary model for in vitro screening of antileishmanial compounds.表达荧光素酶的杜氏利什曼原虫无鞭毛体的构建及其作为抗利什曼原虫化合物体外筛选的初步模型。
Curr Microbiol. 2012 Dec;65(6):696-700. doi: 10.1007/s00284-012-0209-1. Epub 2012 Sep 4.
6
Effect of sodium stibogluconate and pentamidine on in vitro multiplication of Leishmania donovani in peritoneal macrophages from infected and drug-treated BALB/c mice.葡萄糖酸锑钠和喷他脒对来自感染及药物处理的BALB/c小鼠腹腔巨噬细胞内杜氏利什曼原虫体外增殖的影响。
Immunol Cell Biol. 1992 Feb;70 ( Pt 1):25-31. doi: 10.1038/icb.1992.4.
7
Co-administration of glycyrrhizic acid with the antileishmanial drug sodium antimony gluconate (SAG) cures SAG-resistant visceral leishmaniasis.甘草酸与抗利什曼原虫药物葡萄糖酸锑钠(SAG)联合用药可治愈 SAG 耐药性内脏利什曼病。
Int J Antimicrob Agents. 2015 Mar;45(3):268-77. doi: 10.1016/j.ijantimicag.2014.10.023. Epub 2014 Dec 8.
8
The synergistic action of pyrazolopyrimidines and pentavalent antimony against Leishmania donovani and L. braziliensis.吡唑并嘧啶与五价锑对杜氏利什曼原虫和巴西利什曼原虫的协同作用。
Am J Trop Med Hyg. 1988 Sep;39(3):250-5. doi: 10.4269/ajtmh.1988.39.250.
9
Leishmania donovani: an in vitro study of antimony-resistant amphotericin B-sensitive isolates.杜氏利什曼原虫:锑耐药两性霉素B敏感分离株的体外研究
Exp Parasitol. 2006 Dec;114(4):247-52. doi: 10.1016/j.exppara.2006.03.016. Epub 2006 May 23.
10
Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents.利什曼病的化学疗法第十三部分:新型杂环视黄醛 - 双苄叉丙酮杂化物作为抗利什曼原虫剂的设计与合成
Bioorg Med Chem Lett. 2015 Jan 15;25(2):410-3. doi: 10.1016/j.bmcl.2014.09.078. Epub 2014 Oct 2.

引用本文的文献

1
Fexinidazole optimization: enhancing anti-leishmanial profile, metabolic stability and hERG safety.非昔硝唑优化:增强抗利什曼原虫活性、代谢稳定性及人醚 - 去极化激活的钾离子通道安全性
RSC Med Chem. 2024 Aug 30;15(11):3837-52. doi: 10.1039/d4md00426d.
2
Anti- compounds can be screened using spp. expressing red fluorescence ().可以使用表达红色荧光的 spp. 筛选抗化合物()。
Antimicrob Agents Chemother. 2024 Jan 10;68(1):e0050923. doi: 10.1128/aac.00509-23. Epub 2023 Dec 8.
3
Cardiovascular Effects of Environmental Metal Antimony: Redox Dyshomeostasis as the Key Pathogenic Driver.
环境金属锑对心血管的影响:氧化还原失衡作为关键的致病驱动因素。
Antioxid Redox Signal. 2023 Apr;38(10-12):803-823. doi: 10.1089/ars.2022.0185. Epub 2023 Feb 8.
4
Past and future of trypanosomatids high-throughput phenotypic screening.无。
Mem Inst Oswaldo Cruz. 2022 Mar 11;117:e210402. doi: 10.1590/0074-02760210402. eCollection 2022.
5
Amine-Linked Flavonoids as Agents Against Cutaneous Leishmaniasis.胺连接类黄酮作为抗皮肤利什曼病的药物
Antimicrob Agents Chemother. 2023 May 1;65(5). doi: 10.1128/AAC.02165-20. Epub 2021 Mar 8.
6
Leishmanicidal Activity of Betulin Derivatives in Effect on Plasma and Mitochondrial Membrane Potential, and Macrophage Nitric Oxide and Superoxide Production.桦木醇衍生物的杀利什曼原虫活性:对血浆和线粒体膜电位以及巨噬细胞一氧化氮和超氧化物产生的影响
Microorganisms. 2021 Feb 4;9(2):320. doi: 10.3390/microorganisms9020320.
7
Novel 2D and 3D Assays to Determine the Activity of Anti-Leishmanial Drugs.用于测定抗利什曼原虫药物活性的新型二维和三维检测方法。
Microorganisms. 2020 Jun 1;8(6):831. doi: 10.3390/microorganisms8060831.
8
Infectivity and Drug Susceptibility Profiling of Different -Host Cell Combinations.不同宿主细胞组合的感染性和药敏分析
Pathogens. 2020 May 20;9(5):393. doi: 10.3390/pathogens9050393.
9
In-depth comparison of cell-based methodological approaches to determine drug susceptibility of visceral Leishmania isolates.深入比较基于细胞的方法学方法,以确定内脏利什曼原虫分离物的药物敏感性。
PLoS Negl Trop Dis. 2019 Dec 2;13(12):e0007885. doi: 10.1371/journal.pntd.0007885. eCollection 2019 Dec.
10
Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.评估针对细胞内杜氏利什曼原虫的宿主和病原体导向治疗的协同作用。
Int J Parasitol Drugs Drug Resist. 2019 Aug;10:125-132. doi: 10.1016/j.ijpddr.2019.08.004. Epub 2019 Aug 21.